Document Detail


Angiographic patency study of an albumin-free recombinant streptokinase formulation in acute myocardial infarction.
MedLine Citation:
PMID:  15576019     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Fibrinolytic therapy restores coronary patency and reduces mortality in patients with acute myocardial infarction. Albumin is present in most of the streptokinase formulation as a stabilizer but it is not known whether it plays a role in the product's efficacy and safety profiles. The aim of this study was to assess 90 minutes-coronary patency of a new albumin-free recombinant streptokinase (rSK) formulation. METHODS . Patients with ischemic chest pain and ST-segment elevation, less than 12 hours after symptoms onset, without contraindications for fibrinolytic therapy, were included to receive 1.5 x 10(6) IU of rSK in a one-hour intravenous infusion. Angiography was performed 90 minutes after and coronary patency was classified according to the TIMI flow scales. RESULTS: The study enrolled 25 patients, 59.4 +/- 9.2 years-old, 88% men and 92% white. The mean time interval between the symptoms onset and rSK infusion was 3.0 +/- 2.0 hours. Patency rate (TIMI 2-3) of the infarct-related vessel was 72% (18/25). Partial or complete ST-segment resolution was achieved in 17 patients (68%). Hypotension and nauseas were the most frequent adverse events. Haemorrhage or in-hospital deaths were not reported. CONCLUSIONS: This study suggests that intravenous albumin-free rSK is a safe and appropriate therapy to get early (90-minute) coronary patency in patients with acute myocardial infarction.
Authors:
Lorenzo D Llerena; Juan J Quir?s; Benito Sainz; Jos? A Vald?s; Biolkys Zorio; Luis H Villanueva; C?sar E Filgueiras; Francisco Cabrera; Julio C Echarte; Jes?s M P?rez del Todo; Israel Guerrero; Leonardo L?pez; Ernesto J Garc?a; Betty Nadal; Blas Y Betancourt; Gisou D?az-Rojo; Ana I Garc?a; Pedro L?pez-Saura
Related Documents :
2195859 - Magnesium replacement therapy.
3711489 - Elevated serum d dimer: a degradation product of cross-linked fibrin (xdp) after intrav...
8694669 - Admission serum magnesium level does not predict the hospital outcome of patients with ...
3914879 - Failure of intravenous pindolol to reduce the hemodynamic determinants of myocardial ox...
6693639 - Patterns of creatine kinase release during acute myocardial infarction after nonsurgica...
2026469 - Hypermagnesemia following aluminum phosphide poisoning.
8339629 - Clinical significance of pericardial effusion associated with pericarditis in acute q-w...
18072419 - Cardiac disease in dialysis patients in a jamaican hospital: echocardiographic findings...
17456019 - Heart field: from mesoderm to heart tube.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article     Date:  2004-11-26
Journal Detail:
Title:  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Soci?t? canadienne des sciences pharmaceutiques     Volume:  7     ISSN:  1482-1826     ISO Abbreviation:  J Pharm Pharm Sci     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-12-03     Completed Date:  2005-10-31     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  9807281     Medline TA:  J Pharm Pharm Sci     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  372-7     Citation Subset:  IM    
Affiliation:
Institute for Cardiology and Cardiovascular Surgery, Havana.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Female
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy*
Pilot Projects
Streptokinase / adverse effects,  therapeutic use*
Thrombolytic Therapy
Treatment Outcome
Vascular Patency / drug effects
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality.
Next Document:  Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes b...